Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the month of November 2019, specifically dated November 8, 2019. The document serves as a transaction notification regarding dealings in the company's ordinary shares by Persons Discharging Managerial Responsibilities (PDMR) and Persons Closely Associated (PCA) with them. The filing does not contain general business updates or operational reports.
Key Financial Metrics
This filing does not report corporate financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. It exclusively details specific share transactions executed on the London Stock Exchange (XLON) on November 8, 2019.
| Transaction Type | Individual | Volume | Price (GBP) | Instrument |
|---|---|---|---|---|
| Sale | Mrs S Jackson (PDMR) | 1,158 | 17.2835 | Ordinary Shares |
| Repurchase | Mrs S Jackson (PDMR) | 1,149 | 17.2937 | Ordinary Shares |
| Sale | Mr D Jackson (PCA) | 1,158 | 17.2935 | Ordinary Shares |
| Repurchase | Mr D Jackson (PCA) | 1,150 | 17.2905 | Ordinary Shares |
Material Changes
The filing does not provide comparative data against prior periods. The transactions listed are isolated events occurring on a single date (November 8, 2019) and do not represent a material change in the company's financial position or operations.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or contingencies. The nature of the transactions for both Mrs S Jackson and Mr D Jackson is explicitly stated as transfers into an Individual Savings Account (ISA).
Investor Verification Points
- Verify that the transactions were executed for the purpose of transferring shares into an ISA, as stated in the filing.
- Confirm the identity of the transacting parties: Mrs S Jackson (SVP, Global Communications & CEO Office) and Mr D Jackson (PCA of Mrs S Jackson).
- Note that the filing is a regulatory disclosure of insider trading activity and does not reflect broader company performance.
- Check the London Stock Exchange (XLON) for the specific trade execution details if further granularity is required.